Please cite this article as: Kumar M, Lopetegui-Lia N, Malouf CA, Almnajam M, Coll PP, Kim AS. Atrial fibrillation in older adults with cancer. J Geriatr Cardiol 2022; 19(1): 1−8. DOI: 10.11909/j.issn.1671-5411.2022.01.001.
Citation: Please cite this article as: Kumar M, Lopetegui-Lia N, Malouf CA, Almnajam M, Coll PP, Kim AS. Atrial fibrillation in older adults with cancer. J Geriatr Cardiol 2022; 19(1): 1−8. DOI: 10.11909/j.issn.1671-5411.2022.01.001.

Atrial fibrillation in older adults with cancer

  • Cancer and atrial fibrillation (AF) are common co-morbid conditions in older adults. Both cancer and cancer treatment increase the risk of developing new AF which increases morbidity and mortality. Heart rate and rhythm control along with anticoagulation therapy remain the mainstay of treatment of AF in older adults with both cancer and AF. Adjustments to the treatment may be necessary because of drug interactions with concurrent chemotherapy. Cancer and old age increase the risk of both, thromboembolism and bleeding. The risk of these complications is further enhanced by concomitant cancer therapy, frailty, poor nutrition status and, coexisting geriatric syndromes. Therefore, careful attention needs to be given to the risks and benefits of using anticoagulant medications. This review focuses on the management of AF in older patients with cancer, including at the end-of-life care.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return